FDA Inspection
Merck Sharp & Dohme LLCMerck Sharp & Dohme LLC – FDA Inspection, Jan 22, 2025
Record Details
This FDA Inspection record concerns Merck Sharp & Dohme LLC, with an inspection on January 22, 2025, issued by the Baltimore District Office, covering human drugs.
View Company Profile
ID · d27a9329-0c95-402a-83a7-b4d2c220d944
Inspection Facts
- Inspection number
- 1258902
- FDA center
- Human Drugs
Other FDA inspections of Merck Sharp & Dohme LLC
18| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | Not classified | Baltimore District Office | |
| April 26, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| March 4, 2020 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| June 28, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 26, 2018 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Merck Sharp & Dohme LLC
- FDA Inspection 1296670 - 2025-11-21
- FDA Inspection 1210555 - 2023-04-26
- FDA Inspection 1123248 - 2020-03-04
- FDA Inspection 1094564 - 2019-06-28
- FDA Inspection 1073392 - 2018-10-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.